Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Dumka, V. K.
- Safety Assessment of Lincomycin Following Repeated Intramuscular Administration in Goats
Abstract Views :368 |
PDF Views:0
Authors
Affiliations
1 Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, GADVASU, Ludhiana-141004, IN
1 Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, GADVASU, Ludhiana-141004, IN
Source
Toxicology International (Formerly Indian Journal of Toxicology), Vol 22, No 3 (2015), Pagination: 92-95Abstract
A safety evaluation of lincomycin was carried out to assess clinical impact of intramuscular administration of lincomycin on various haematological and biochemical parameters in goats to establish safety profile of lincomycin. Six healthy female goats were treated with single intramuscular dose of lincomycin @10.0 mg/kg body weight. The blood samples were collected at day 0 (before administration of drugs), and on 6th day of drug administration. The hematological and plasma biochemical analysis were done. No significant alterations (p < 0.05) were found in the mean value of haematological and biochemical parameters during treatment period except for significant elevation in values of Lactate dehydrogenase and Creatinine. Repeated intramuscular administration of lincomycin (10.0 mg/kg) for 5 days in goat was found safe. Thus, lincomycin may be useful to treat bacterial diseases accompanied by fever, pain and other inflammatory condition in goats.Keywords
Goats, Lincomycin, Safety Assessment.References
- Collignon P, Courvalin P, Aidara-Kane A. Clinical importance of antimicrobial drugs in human health. Guide to Antimicrobial Use in Animals. UK: Blackwell Publishing. 2008. p. 44–58.
- Giguere S. Lincosamides, pleuromutilins, and Streptogramins. Giguere, editor. Antimicrobial Therapy in Veterinary Medicine. 4th ed; 2006.
- Barragry TB. Veterinary drug therapy. Baltimore: Lea and Febiger; 1994. p. 251–62.
- Papich MG, Riviere JE. Chloramphenicol and derivatives, macrolides, lincosamides, and miscellaneous antimicrobials. Riviere JE, Papich MG, editors. Veterinary Pharmacology and Therapeutics. 9th ed; 2009. p. 963–5.
- Bhavsar SK, Verma MP, Thaker AM. Pharmacokinetics, tissue concentration, and safety of multiple dose intravenous administration of ciprofloxacin in cow calves. J Vet Pharmacol Toxicol. 2004; 3(1):27–34.
- Khargharia S, Barua CC, Nath N, Bhattachrya M. Blood biochemical studies of enrofloxacin in Yak after intravenous administration. Iranian J Pharmacol Therap. 2007; 6:137–8.
- Patel JH, Varia RD, Patel UD, Vihol PD, Bhavsar SK, Thaker AM. Safety of levofloxacin following repeated oral administration in white leg horn layer birds. Vet World. 2009; 2(4):137–9.
- More T. Animal clinical biochemistry. New Delhi: Kalyani Publishers; 2006.
- Brar RS, Sandhu HS, Singh A. Veterinary clinical diagnosis by laboratory methods. Ludhiana-New Delhi: Kalyani Publishers; 2000.
- P53 and It’s Applications in Cancer Therapy
Abstract Views :419 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Rasalpura - 453446, Mhow, Madhya Pradesh, IN
2 Department of Pharmacology and Toxicology, GADVASU, Ludhiana - 141012, Punjab, IN
1 Department of Pharmacology and Toxicology, College of Veterinary Science and Animal Husbandry, Rasalpura - 453446, Mhow, Madhya Pradesh, IN
2 Department of Pharmacology and Toxicology, GADVASU, Ludhiana - 141012, Punjab, IN
Source
Toxicology International (Formerly Indian Journal of Toxicology), Vol 22, No 2 (2015), Pagination: 9-18Abstract
P53 is a tumour suppressor protein encoded by the TP53 gene, which is one of the most commonly mutated gene in human and animal cancers. Missense Mutation of the p53 gene is the most prevalent genetic abnormalities which gives rise to full length p53 containing single amino acid substitution within the sequence-specific DNA binding domain (|Greenblatt et al., 1994)14. p53 plays anti-cancer role, through several mechanisms namely by activating DNA repair, initiating apoptosis and inducing growth arrest. By managing the DNA damage, p53 gene plays an important role in maintaining integrity and stability of the genome and therefore, it has been described as "the guardian of the genome". Restoring p53 function is a major step in the treatment of many cancers by following different strategies like, gene replacement therapy using wild-type p53, reactivation of p53 function, inhibition of p53-Mdm2 interaction etc. Advexin is an Adeno-p53 vector, recognized as an orphan drug by USA, Food and Drug administration in 2003, provides delivery of wild-type p53 to cancer cells and demonstrates anticancer activity following adequate expression of p53 (Nemunaitis and Nemunaitis, 2008)27. Similarly, MI-319 restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals (Mohammad et al., 2009)25. These strategies of p53-based cancer therapy differ greatly between themselves both in the mode of action and the degree of success seen in experimental models. Cancer therapy based around p53 proves to be more efficacious, especially in terms of specificity. But the innovation of successful p53-based cancer therapies is only limited by our understanding of p53 biology and the creative use of such knowledge. In future, p53-based cancer therapy can be a valuable option for the treatment of a variety of tumours in human as well as animals.Keywords
P53/Cancer Therapy.References
- Amaral. The role of p53 in apoptosis. Discovery Med. 2010; 9(45):145–52.
- Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 1998; 282:290–3.
- Bertholet S, Iggo R, Corradin G. Cytotoxic T lymphocyte responces to wild-type and mutant mouse p53 peptides. Eur J Immunol. 1997; 27:798–801.
- Bottger A, Bottger V, Sparks A. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol. 1997; 7:860–9.
- Bunz F. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998; 282:1497–501.
- Bykov VJ, Selivanova G, Wiman KG. Small molecules that reactivate mutant p53. Eur J Cancer. 2003; 39:1828–34.
- Cai DW, Mukhopadhyay T, Liu YJ. Stable expression of the wild-type p53 gene in human lung-cancer cells after retrovirus mediated gene-transfer. Human Gene Ther. 1993; 4:617–24.
- Chen J, Wu X, Lin J, Levine AJ. Mdm2 inhibits the G1 arrest and apoptosis functions of the p53 tumour suppressor protein. Mol Cell Biol. 1996; 16:2445–52.
- Ciernik IF, Berzofsky J, Carbone DP. Mutant oncopeptide immunization induces CTL specifically lysing tumour-cells endogenously expressing the corresponding intact mutant p53. Hybridoma. 1995; 14:139–42.
- Conseiller E, Debussche L, Landais D. CTS-1: A p53-derived chimeric tumour suppressor gene with enhanced in vitro apoptotic properties. J Clin Invest. 1998; 101:120–7.
- Cui R, Widlund HR, Feige E, Lin JY, Wilensky DL, Igras VE, D’Orazio J, Fung CY, Schanbacher CF, Granter SR, Fisher DE. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell. 2007; 128(5):853–64.
- Farhood H, Gao X, Son K. Cationic liposomes for direct gene-transfer in therapy of cancer and other diseases. Ann Ny Acad Sci. 1994; 716:23–35.
- Gallagher WM, Brown R. p53-oriented cancer therapies: current progress. Annals Oncol. 1999; 10:139–50.
- Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994; 54:4855–78.
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell.2000; 100:57–70.
- Howard MIC, Kershaw T, Gibb B. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional p27 and p34.5. Gene Ther. 1998; 5:1137–47.
- Idogawa M, Ohashi T, Sasaki Y, Maruyama R, Kashima L, Suzuki H, Tokino T. Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites. Hum Mol Genet. 2014; 23:2847–57.
- Issaeva N, Friedler A, Bozko P, Wiman KG, Fersht AR, Selivanova G. Rescue of mutants of the tumour suppressor p53 in cancer cells by a designed peptide. Proc Nat Acad Sci. 2003; 100:13303–7.
- Jeffers JR, Parganas E, Lee Y, Yang C, Wang J. Puma is an essential mediator of p53-dependent and independent apoptotic pathways. Cancer Cell. 2003; 4(4):321–8.
- Joerger AC, Fersht AR. Structural biology of the tumor suppressor p53. Annu Rev Biochem. 2008; 77:557–82.
- Koshland DE. Molecule of the year. Science. 1993; 262(5142):1953.
- Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007; 87(1):99–163.
- Lesoonwood LA, Kim WH, Kleinman HK. Systemic gene-therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude-mice. Human Gene Ther. 1995; 6:395–405.
- Maier B, Gluba W, Bernier B. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004; 18(3):306–19.
- Mohammad RM, Wu J, Azmi AS, Aboukameel A, Sosin A. An Mdm2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals. Mol. Cancer. 2009; 8:115.
- Moroni MC, Hickman ES, Denchi EL, Caprara G. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol. 2001; 3(6):552–8.
- Nemunaitis K, Nemunaitis S. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome. J Clin Oncol. 2008; 20:2408–18.
- Nielsen LL, Maneval DC. p53: Tumour suppressor gene therapy for cancer. Cancer Gene Ther. 1997; 4:129–38.
- Oconnor PM, Jackman J, Bae I. Characterization of the p53 tumour suppressor pathway in cell lines of the national cancer institute anticancer drug screen and correlations with the growth inhibitory potency of 123 anticancer agents. Cancer Res. 1997; 57:4285–300.
- Roth JA, Cristiano RJ. Gene therapy for cancer: What have we done and where are we going? J Nat Cancer Inst. 1997; 89:21–39.
- Sakaguchi K, Herrera JE, Saito S. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998; 12:2831–41.
- Shangary S, Wang S. Small-molecule inhibitors of the Mdm2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol. 2009; 49:223–41.
- Snyder EL, Meade BR, Saenz CC, Dowdy SF. Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. Proc Biol. 2004; 2:36.
- Takashi D, Bruce SE. Induction of wild-type p53 activity in human cancer cells by ribozyme that repair mutant p53 transcripts. Future Oncol. 2000; 4(6):759–68.
- Tamura M, Sasaki Y, Kobashi K, Takeda K, Nakagaki T, Idogawa M, Tokino T. CRKL oncogene is downregulated by p53 through miR-200s. Cancer Science. 2015; 106(7):1–8.
- Tamura M, Sasaki Y, Koyama R, Takeda K, Idogawa M, Tokino T. Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness. Oncogene. 2014; 33:4837–46.
- Tang X, Zhu Y, Han L, Kim AL, Kopelovich L, Bickers DR, Athar M. CP-31398 restores mutant p53 tumour suppressor function and inhibits UVB-induced skin carcinogenesis in mice. J Clin Invest. 2002; 112(12):3753–64.
- Thomas M, Massimi P, Banks L. HPV-18 E6 inhibits DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence. Oncogene. 1996; 13:471–80.
- Vakhrusheva O, Smolka C, Gajawada P, Kostin S, Boettger T, Kubin T, Braun T. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res. 2008; 102(6):703–10.
- Vegad JL. Neoplasia. In: A text book of veterinary general pathology (2nd edn). International book publishing distributing corporation, Lucknow. 2007; 277–335.
- Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000; 408:307–10.
- Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nature Reviews Cancer. 2013; 13:83–96.
- Wang W, El-Deiry WS. Restoration of p53 to limit tumour growth. Curr Opin Oncol. 2008; 20(1):90–6.
- Wolff JA, Malone RW, Williams P. Direct gene-transfer into mouse muscle in vivo. Science. 1990; 247:1465–8.
- Wu GS, Burns TF, McDonald ER. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet. 1997; 17(2):141–3.
- Wu N, Rollin J, Masse I, Lamartine J, Gidrol X. P53 regulates human keratinocytes proliferation by MYC –regulated gene network and differentiation commitment through cell adhesion-related gene network. The Journal of Biological Chemistry. 2012; 287(8):5627–38.
- Xu L, Pirollo KF, Chang EH. Transferrin-liposome-mediated p53 sensitisation of squamous cell carcinoma of the head and neck to radiation in vitro. Human Gene Ther. 1997; 8:467–75.
- Zhang J, Sun Q, Zhang Z, Ge S, Han ZG, Chen WT. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene. 2013; 32:61–9.
- Flubendiamide and Lead Exposure Alters Glial Fibrillary Acidic Protein and Aspartic Acid Concentrations in Cerebrospinal Fluid in Buffalo Calves
Abstract Views :388 |
PDF Views:0
Authors
Affiliations
1 Department of Veterinary Pharmacology and Toxicology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, IN
2 Department of Veterinary Medicine, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, IN
1 Department of Veterinary Pharmacology and Toxicology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, IN
2 Department of Veterinary Medicine, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, IN
Source
Toxicology International (Formerly Indian Journal of Toxicology), Vol 23, No 1 (2016), Pagination: 27-32Abstract
Changes in glial fibrillary acidic protein (GFAP) and aspartic acid (AA) concentrations in CSF following flubendiamide and lead exposure was studied. Male buffalo calves received daily oral dose of flubendiamide alone (n=4) @ 0.024mg/ kg/ day or lead acetate alone (n=4) @ 9.2 mg/ kg/ day or a combination of these two (n=4) for 90 days. Blood and CSF samples were collected and analyzed. GFAP in CSF did not alter in animals receiving flubendiamide alone. However, a significant increase in GFAP concentration in CSF was observed in animals receiving lead acetate. GFAP concentration showed a positive correlation (r = +0.545) with blood lead concentration in lead exposed animals, but no significant correlation was evident in animals exposed to both lead and flubendiamide. On the basis of results, it can be concluded that Aspartic acid concentration in CSF did not change significantly in lead treated animals, but increased significantly in flubendiamide treated animals. No significant alteration in AA level in CSF was observed in combined flubendiamide and lead treated animals. Flubendiamide exposure is associated with increase in AA level in CSF. Flubendiamide may have interactive effects with lead as evident from increase in GFAP and AA level in CSF after their combined exposure. This is the first report documenting alterations in GFAP and AA concentrations in CSF after flubendiamide exposure in mammals.Keywords
CSF, Heavy Metal, Pesticide, Toxicity.References
- Miller GT, Sustaining the Earth. 6th ed. California: Thompson Learning Inc; 2004.
- Dondero F, Banni M, Negri A, Botti L, Dagnino A, Viarengo A. Interactions of a pesticide/ heavy metal mixture in marine bivalves: A trascriptomic assessment. BMC Genomics 2011;(12): 195; doi:10.1186/1471-2164-12-195.
- Lahm G, Cordova D, Barry JD. New and selective ryanodine receptor activators for insect control. Bioorganic Med Chem 2009; (17): 4127-33.
- Ranjan A, Dumka VK, Singh ND. Effect of flubendiamide, lead and their combined exposure on erythrocytic indices in water buffalo calves. B Environ Contam Toxicol 2014; (92): 410-4.
- Swarup D, Patra RC. Environmental pollution and its impact of domestic animals and wildlife. Indian J Anim Sci 2005; (75): 231-40.
- Krishnaswamy K, Kumar BD. Lead toxicity. Indian Pediatrics 1998; (35) 209-16.
- Bharathidhasani S, Kaur H, Mani V, Kewalramani N. Lead and cadmium contents of animal feed resources in Haryana. Indian J Anim Sci 2008; (78): 1268-72.
- Swarup D, Patra RC, Naresh R, Kumar P, Shekhar P. Blood lead levels in lactating cows reared around polluted localities: transfer of lead in to milk. Sci Total Environ 2005; (347): 106-10.
- Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit; 2006; (12): 57-65.
- ATSDR. Toxicological Profile of Lead. Atlanta, USA: Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services; 2007.
- Chen MH, Bullock R, Graham DI, Miller JD, Mc-Culloch J. Ischemic neuronal damage after acute subdural hematoma in the rat: effects of pretreatment with a glutamate antagonist. J Neurosurg 1991; (74): 944-50.
- Stover JF, Pleines UE, Morganti-Kossmann MC, Kossmann T, Lowitzsch K, Kempski OS. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 1997; (27): 1038-43.
- Zhang H, Zhai SD, Li YM, Chen LR. Effect of different sample pretreatment methods on the concentrations of excitatory amino acids in cerebrospinal fluid determined by high-performance liquid chromatography. J Chromatogr B 2003; (784): 131-5.
- Radostits OM, Blood DC, Gay CC, Hinchcliff KW. Veterinary medicine: A textbook of diseases of cattle, sheep, pigs, goats and horses. 9thedn. London: W B Saunders; 2000.
- Sujatha K, Sriraman PK, Naidu NRG. Haematobiochemical alterations in lead toxicity in buffalo calves. Indian J Vet Pathol 2006; (30): 69-70.
- Chowdhury AR, Naha N. Heavy metal induced toxicity in male reproductive system. Indian J Toxicol 2002; (9): 61-7.
- Dwivedi SK, Swarup D, Dey S, Patra RC. Lead poisoning in cattle and buffalo near primary lead zinc smelter in India. Vet Human Toxicol 2001; (43): 93-4.
- Choubisa SL, Mishra GV, Sheikh Z, Bhardwaj B, Mali P, Jaroli VJ. Food, fluoride, and fluorosis in domestic ruminants in the Dungarpur district of Rajasthan, India. Fluoride 2011; (44): 70-6.
- Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbrnikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke 1991; (22): 1254-8.
- De-Armond SJ, Fajardo M, Naughton S.A. Degradation of glial fibrillary acidic protein by a calcium dependent proteinase: An electroblot study. Brain Res 1981; (262): 275-82.
- Struzynska L, Dabrowska-Bouta B, Koza K, Sulkowski G. Inflammation-like glial response in lead-exposed immature brain. Toxicol Sci 2007; (95): 156-62.
- Gong Z, Little AR, Jr-El-Fawal H, Evans HL. Trimethyl lead neurotoxicity in the rat: changes in glial fibrillary acidic protein (GFAP). Ach Indust Hyg Toxicol 1995; (46): 381-90.
- Tiffany-Castiglioni E, Zmudzki J, Bratton GR. Cellular targets of lead toxicity: In vitro models. Toxicol 1986; (42): 305-15.
- Stoltenburg-Didinger G, Punder I, Peters B, Marcinkowski M, Herbst H, Winneke G, Wiegand H. Glial fibrillary acidic protein and RNA expression in adult rat hippocampus following low-level lead exposure during development. Histochem Cell Biol 1986; (105): 431-42.
- Griffin SWT, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE. Glial-neuronal interactions in Alzheimer’s disease: The potential role of a ‘‘cytokine cycle’’ in disease progression. Brain Pathol 1998; (8): 65-72.
- Hong Z, Xinding Z, Tianlin Z, Liren C. Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clinic Chem 2001; (47): 1458-62.
- Bullock R, Fujisawa H. The role of glutamate antagonists for the treatment of CNS injury. J Neurotrauma 1992; (9): S 443-62.
- Ince E, Karagol U, Deda G. Excitatory amino acid levels in cerebrospinal fluid of patients with infantile spasms. Acta Paediatrica 1997; (86): 1333-6.
- Araki K, Harada M, Ueda Y, Takino T, Kuriyama K. Alteration of amino acid content of cerebrospinal fluid from patients with epilepsy. Acta Neurol Scand 1988 (78): 473-9.
- Smith MO, George LW. Diseases of the Nervous System. In: Large Animal Internal Medicine, 4th Edn (Smith BP, Editor), Mosby, Elsevier, Missouri 2009.
- Immune Response to Sub Acute Toxicity of Thiacloprid Insecticide in Gallus domesticus
Abstract Views :296 |
PDF Views:0
Authors
Saloni Singla
1,
V. K. Dumka
1
Affiliations
1 Department of Veterinary Pharmacology and Toxicology, Guru Angad Dev Veterinary and Animal Science University, Ludhiana, IN
1 Department of Veterinary Pharmacology and Toxicology, Guru Angad Dev Veterinary and Animal Science University, Ludhiana, IN
Source
Toxicology International (Formerly Indian Journal of Toxicology), Vol 24, No 3 (2017), Pagination: 249-253Abstract
Thiacloprid is fairly a new chemical, but it has established itself as key component in insecticides because of its selectivity and low toxicity. It is effective on contact and via stomach action and bind agonistically to the nicotinic acetylcholine receptors in the CNS of insects, affecting synaptic transmission and leading to disruption of the nervous system. The immune system is a host defense system comprising many biological structures and processes within an organism that protects against disease. It can be the target of many chemicals, with potentially severe adverse effects on the host’s health. The health implications of these immune dysfunctions are increased risk of infectious diseases; development of neoplasia; autoimmune disorders and allergies. Estimation of total immunoglobulins and enumeration of B and T lymphocytes in blood after repeated oral administration of thiacloprid at the dose rate of 10 mg/kg/day revealed no significant alterations in Gallus domesticus. The observed findings in the present study indicated that repeated thiacloprid exposure in poultry birds did not adversely affect the immune status of Gallus domesticus and thus is immunologically safer insecticide.Keywords
Toxicity, Gallus domesticus, Thiacloprid, Insecticide, Immune System.References
- Uok K. Neonicotinoid Insecticides. Microbiology and Molecular Genetics. 2006; 2: 46-52.
- National Registration Authority for Agricultural and Veterinary Chemicals. ISSN 1443-1335, Evaluation of the new active Thiacloprid in the new product Calypos 480 SC Insecticide. 2001.
- Tomizawa M and Casida JE. Neonicotinoid insecticide toxicology: mechanisms of selective action. Annu. Rev. Pharmacol. Toxicol. 2005; 45: 247-268.
- Felsot AS and Ruppert JR. Imidacloprid Residues in Willapa Bay (Washington State) Water and Sediment Following Application for Control of Burrowing Shrimp J. Agric. Food Chem. 2002; 50(15): 4417-23.
- Ware GW and Whitacre DM. An Introduction to Insecticides fourth ed., MeisterPro Information Resources, A division of Meister Media Worldwide, Willoughby, Ohio, USA. 2004.
- Anatra-M. and Durkin P. Imidacloprid. Human health assessment and ecological risk assessment Final report. Syracuse Environmental Research Associates, Inc., New York, SERA TR 2005; 5- 43-24-03.
- Karabaym NUand Oguz, MG. Cytogenetic and genotoxic effects of the insecticides, imidacloprid and methamidophos Genet. Mol. Res. 2005; 4: 653-62.
- Demsia G, Vlastos D, Goumenou M, Mathopoulos DP. Assesment of the genotoxicity of imidacloprid and metalaxyl in cultured human lymphocytes and rat bone marrow Mutat. Res. 2007; 634: 32-39.
- Abou-Donia MB, Goldstein LB, Bulman S, Tu T, Khan WA, Dechkovskaia.AM and Abdel-Rahman AA. Imidacloprid induces neurobehavioral deficits an increase expression of glial fibrillary acidic protein in the motor cortex and hippocampus in offspring rats following in utero exposure. J.Toxicol. Environ. Health. 2008;. 71: 119–130.
- Holsapple MP. Developmental immunotoxicity testing: a review.Toxicolology. 2003; 185: 193-203.
- Meguire TC, Pfeiffer NE, Weikel JM, Bartsch, RC. Failure of cloistral immunoglobulin transfer in calves dying from infectious disease. JAVMA 1976; 169: 713-71.
- Mcewan AD, Fisher EW, Selman IE Penhale WJ. A turbidity test for the estimation of immunoglobulin levels in neonatal calf serum. Clin. Chim. Acta, 1970; 27: 155-63.
- Pfeiffer NE, Mcguire TC, Bendel RB. Quantitation of bovine immunoglobulins: comparison of single radial immunodiffusion, zinc sulfate turbidity, serum electrophoresis, and refractometer methods. Am J Vet Res, 1977; 38:693-698.
- Boyum A. Separation of leukocytes from blood and bone marrow with special reference to factors which influence and modify redimentation properties of hematopoietic cells. Scandinavian Journal of Clinical and Laboratory Investigation 1968; 21: 1.
- Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus-derived murine lymphocytes European Journal of Immunology. 1973; 3: 645-49.
- Street JC. and Sharma RP. Alteration of induced cellular and humoral responses by pesticide and chemicals of environmental concern: Quantitative studies of immunosuppression by DDT, Aroclor 1254, carbaryl, carbofuran and Methylparathion. Toxicology and Applied Pharmacology 1995; 32: 58.
- Goyal S and Sandhu HS. Immunological effects of sub chronic exposure to Thiacloprid insecticide in Gallus domesticus. The Veterinary Practitioner 2012; 13(2) 226-28.
- Saha S. and Banerjee D. Effect of sub-chronic lindane exposure on humoral and cell-mediated immune responses in albino rats. Bulletin of Environmental Contamination and Toxicology.1993; 51: 795.
- Khurana R and Chauhan RS. Immunopathological effects of lindane on humoral immune response in sheep. Journal of Immunology and Immunopathology1999; 1: 67-70.
- Kumar S. Immunotoxic effects of endosulfan and cypermethrin in chickens. M.V.Sc. Thesis, CCS Haryana Agricultural University, Hisar. 1994.
- Burns LA, Meade BJ and Murson AE. Toxic responses of the immune system. In: Klaassen C D.(ed) Casarett and Doull’s Toxicology: The Basic Science of Poisons. 5th edn. 1996; p 355-402. McGraw Hill, New York.
- Ringer RK. PBB fed to immature chickens: Its effects on organ weights and function and on the cardiovascular system. Environmental Health Perspectives. 1978; 23: 247-55.
- Sharma RP. Immunotoxicity. In: Gupta R C (ed) Veterinary Toxicology Basic and Clinical Principles. 2007; p 289-301. Academic Press Inc. San Diego.
- Tamang RK, Gupta G and Chauhan H. In vivo immunosuppression by synthetic pyrethroid (cypermethrin) pesticide in mice and goats. Veterinary Immunology and Immunopathology. 1988; 19: 299-305.
- Blaylock RL. Suppression of cellular immune responses in BALB/c mice following oral exposure to permethrin. Bulletin of Environmental Contamination and Toxicology. 1995; 54: 768-74.
- Casale GP, Cohen SD and DiCapua RA. The effects of organophosphate-induced cholinergic stimulation on the antibody response to sheep erythrocytes in inbred mice. Toxicology and Applied Pharmacology.1983; 68: 198-205.
- Chauhan RS and Tripathi BN. In: Veterinary Immunology Pathology Theory and Practice. International Book Distributing Co. Lucknow. 2002.
- Parham P. The Immune System, Garland Science Publishing, New York. 2005.
- Holtmeier W and Kabelitz D. Gamma delta T cells link innate and adaptive immune responses. Chemistry of Immunology Allergy 1990; 86: 151–83.
- Katsenovich LA, Ruzybakiev, RM and Fedorin LA. T-and B-immunity in patients with pesticide poisoning. Gig. Tr. Prof Zabo. 1981; 4: 17.
- Amelioration of Quinalphos-Induced Oxidative Stress by Emblica officinalis Fruit Extracts in Rats
Abstract Views :316 |
PDF Views:0
Authors
Affiliations
1 Department of Veterinary Pharmacology and Toxicology, CSKHPKV, Palampur, IN
2 Department of Veterinary Pharmacology and Toxicology, GADVASU, Ludhiana, IN
3 Department of Veterinary Pathology, GADVASU, Ludhiana, IN
1 Department of Veterinary Pharmacology and Toxicology, CSKHPKV, Palampur, IN
2 Department of Veterinary Pharmacology and Toxicology, GADVASU, Ludhiana, IN
3 Department of Veterinary Pathology, GADVASU, Ludhiana, IN
Source
Toxicology International (Formerly Indian Journal of Toxicology), Vol 24, No 3 (2017), Pagination: 301-308Abstract
The fruit of Emblica officinalis (commonly known Amla) contain potent antioxidants and is most commonly used in the Ayurveda for the treatment of various diseases. Quinalphos- a organophorus insecticide is known to alter antioxidant defense system in mammals. With this premise, experiment was planned with objective to study the effect of amla fruit extract supplementation on quinalphos induced oxidative stress. Twenty-four Sprague-Dawley rats were homogenously divided into six groups of four animals each. Group I was kept as control. Group II was orally given quinalphos at the dose rate of 2 mg.kg-1. day-1. Group III and V were orally gavaged with amla in sugar and honey bases respectively at the dose rate of 50 μg.kg-1.day-1 whereas group IV and VI were orally dosed with quinalphos along with amla in sugar and honey bases respectively at above mentioned dose rates from day 16-45. The various indices of antioxidant status were analyzed in major organs of treatment groups viz. Liver, kidney and brain. Sub chronic quinalphos administration produced oxidative stress in rats as evidenced by increase in lipid peroxidation, glutathione peroxidase and decline in superoxide dismutase. Oral supplementation of amla extract in sugar and honey bases provided partially amelioration against altered antioxidant status following sub chronic quinalphos exposure. Results of histopathological study were also in corroboration with blood antioxidant status validating amla in either bases was unable to provide full protection against quinalphos induced toxicity in rats.References
- Sreeshitha S.G. 2012. ‘Influence of subchronic oral exposure of quinalphos on the pharmacokinetics of lincomycin in buffalo calves. ’M. V. Sc. Thesis submitted to Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana.
- Extoxnet. 2000. (Extension Toxicology Network). Cholinesterase Inhibition, available online: http://ace.orst.edu/cgi-bin/mfs/01/tibs/cholines.htm
- Singh S K, Tripathi P K, Yadav R P, Singh D and Singh A. 2004. Toxicity of malathion and carbaryl pesticides: Effect on some biochemical profiles of freshwater fish Colisa fasciatus. Bulletin of Environmental Contamination and Toxicology 72: 592-99.
- Hayes W. J. and Laws E. R. 1991. Handbook of pesticides toxicology. Academic Press, New York.
- Katti G. and Verma S. 1992. Persistence of quinalphos against pests under Indian conditions. Pesticide information 18: 37-40.
- Murphy S. D. 1980. Toxic interactions with dermal exposure to organophosphate insecticides. Developments in Toxicology and Environmental Science 8: 615-21.
- Dhaliwal G S, Arora R, Dhawan A K and Singh B. 2000. Intensive Agriculture and Pest Problems: A case study of Punjab, Indian Journal of Ecology 27(2): 109-30.
- Gupta A, Gupta A and Shukla G S. 1998. Effects of neonatal quinalphos exposure and subsequent withdrawal on free radical generation and antioxidative defenses in developing rat brain. Journal of Applied Toxicology 18(1): 71–77.
- Debnath D. and Mandal T. K. 2000. Study of quinalphos (an environmental oestrogenic insecticide) formulation (Ekalux 25 E.C.)-induced damage of the testicular tissues and antioxidant defence systems in Sprague-Dawley albino rats. Journal of Applied Toxicology 20(3): 197-204.
- Dwivedi D, Das M and Khanna S K. 1998. Role of cytochrome P-450 in quinalphos toxicity: effect on hepatic and brain antioxidant enzymes in rats. Food and Chemical Toxicology 36(5): 437-44.
- Behrends A, Hardeland R, Ness H, Grube S, Poeggeler B, Haldar C (2004) Photocatalytic actions of the pesticide metabolite 2-hydroxyquinoxaline: destruction of antioxidant vitamins and biogenic amines—implications of organic redox cycling. Redox Rep 9: 279–288
- Xu B. J., Zheng Y. N. and Sung C. K. 2005. Natural medicines for alcoholism treatment: a review Drug and alcohol review 24: 525–536.
- Reddy VD, Padmavathi P, Gopi S, Paramahamsa M, Varadacharyulu N. Ch. 2010. Protective effect of emblica officinalis against alcohol-induced hepatic injury by ameliorating oxidative stress in rats. Ind J Clin Biochem (Oct-Dec 2010) 25(4):419–424.
- Reddy VD, Padmavathi P, Varadacharyulu NCh. Emblica officinalis protects against alcohol‑induced liver mitochondrial dysfunction in rats. J Med Food 2009;12:327‑33.
- Chen TS, Liou SY, Chang YL. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med 2009;37:19‑25.
- Shivananjappa MM, Joshi MK. Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2). Pharm Biol 2012;50:497‑505.
- Dasaroju S and Gottumukkala K M. 2014. Current Trends in the Research of Emblica officinalis (Amla): A Pharmacological Perspective. Int. J. Pharm. Sci. Rev. Res., 24(2), 150-159.
- Chakraborty D and Verma R.2010. Ameliorative effect of Emblica officinalis aqueous extract on ochratoxin-induced lipid peroxidation in the kidney and liver of mice. International Journal of Occupational Medicine and Environmental Health 2010;23(1):63 – 73.
- Vasant R. A and Narasimhacharya A. V. R. L. 2012. Amla as an antihyperglycemic and hepato-renal protective agent in fluoride induced toxicity. J Pharm Bioallied Sci. 4(3): 250–254.
- Virk P, Elobeid M, Hamad S, Korany Z, Al-Amin M, Omer M D S, AlOlayan E, Siddiqui M I and Mirghani N M. 2013. Ameliorative effects of Embilica officinalis and Rosmarinus officinalis on cadmium-induced oxidative stress in wistar rats. Journal of Medicinal Plant Research Vol. 7(14), pp. 805-818.
- Surana B, Mehta J, Seshadri S. 2008. Toxicological Effects of Quinalphos and its Subsequent Reversal by Using Root Extract of Withania somnifera and Leaf Pulp of Aloe barbadensis. Journal of the Indian Society of Toxicology Volume : 4, Issue : 2 First page : ( 2) Last page : ( 5).
- Aebi, H. E., 1983. Methods of Enzymatic Analysis Vol ΙΙΙ. In Bergmeyer, HO. (ed.), Catalase, New York, Academic press, pp. 273-386.
- Marklund, S., Marklund, G., 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474.
- Shafiq-Ur-Rehman, Lead-induced regional lipid peroxidation in brain, Toxicol. Lett. 21 (1984) 333-337.
- Luna L G. 1968. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, 3rd ed. McGraw-Hill, New York.
- Daundkar P.S. and Rampal S. 2014. Evaluation of ameliorative potential of selenium oncarbendazim induced oxidative stress in male goats. Environmental Toxicology and Pharmacology 3 8: 711–719.
- Bhumika S, Jaya M and Sriram S. 2008.Toxicological effects of quinalphos and its subsequent reversal by using ischolar_main extract of withania somnifera and leaf pulp of aloe barbadensis. Journal of the Indian Society of Toxicology 4(2): 1-5.
- Subramaneyaan M, Jain S, Yadav C, Arora V K, Banerjee B D and Ahmed R S. 2012. Quinalphos induced oxidative stress and histoarcheitectural alterations in adult male albino rats. Environmental Toxicology and Pharmacology 34(3): 673-8.
- Yokozawa T, Kim HY, Kim HJ, Tanaka T, Sugino H, Okubo T, et al. Amla (Emblica officinalis Gaertn.) attenuates age‑related renal dysfunction by oxidative stress. J Agric Food Chem 2007;55:7744‑52.
- Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 1999;37:676‑80.
- Sharma A, Sharma MK, Kumar M. Modulatory role of Emblica officinalis fruit extract against arsenic induced oxidative stress in Swiss albino mice. Chem Biol Interact 2009;180:20‑30.
- Sultana S, Ahmad S, Khan N, Jahangir T. Effect of Emblica officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J Exp Biol 2005;43:430‑6.
- Toxicological Sequelae of Pesticide Combinations Exposure in Buffalo Mesenchymal Stem Cells under In Vitro
Abstract Views :120 |
PDF Views:0
Authors
Affiliations
1 Department of Veterinary Pharmacology and Toxicology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, Punjab, IN
2 Department of Veterinary Physiology and Biochemistry, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, Punjab, IN
3 Department of Veterinary Surgery and Radiology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, Punjab, IN
1 Department of Veterinary Pharmacology and Toxicology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, Punjab, IN
2 Department of Veterinary Physiology and Biochemistry, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, Punjab, IN
3 Department of Veterinary Surgery and Radiology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, Punjab, IN
Source
Toxicology International (Formerly Indian Journal of Toxicology), Vol 29, No 1 (2022), Pagination: 1-14Abstract
The presence of one or more pesticides in a variety of mediums is responsible for their indirect toxicological events leading to cell senescence. In the present investigation, the endeavor was made to see the effect of pesticides Car-Benda-Zim (CBZ) and IMIdacloprid (IMI) alone and in combination with bone marrow-derived Mesenchymal Stem Cells (bMSCs) of buffalo origin. Isolated and cultured bMSCs were exposed to CBZ and IMI alone and in combinations at lower doses. Cells were observed for alterations in cell morphology, oxidative stress, mitochondrial damage and cellular senescence. bMSCs characterized for stem cell surface markers and found to be positive for AP, CD73 and OCT4. bMSCs exposed to IC25, IC12.5 and IC6.25 CBZ and IMI alone and combinations of IC12.5 and IC6.25 of CBZ and IMI. Results revealed significant reduction (p≤0.05) in cell viability noticed on microscopic examination along with loss of normal cell morphology and increased in Reactive Oxygen Species (ROS) positive cells, cells with loss of ΔΨm and number of senescent cells in CBZ and IMI treated groups. Lower dose combination groups showed elevated effects when compared with higher dose alone treated groups and control groups. Present findings suggest that CBZ and IMI induced cytotoxicity in bMSCs mediated via ROS production, altered ΔΨm leading to the cell damage and predisposing senescence process. Moreover, the co-existence of CBZ and IMI in a medium has a considerably more toxic effect than their individual effect.Keywords
Carbendazim, Imidacloprid, Stem Cells, Mitochondrial Transmemberane Potential, Reactive (ROS), SenescenceReferences
- Damalas CA, Koutroubas SD. Farmers’ Training on pesticide use is associated with elevated safety behavior. Toxics. 2017; 5(3):19. https://doi.org/10.3390/toxics5030019. PMID: 29051451; PMCID: PMC5634698.
- Patil N, Lonare M, Sharma M, Lalhriatpuia P, Saini S, Rampal S. Hemato-biochemical alterations mediated by carbendazim exposure and protective effect of quercetin in male rats. Toxicol Int. 2018; 25(1):1-12. https://doi:10.22506/ti/2018/v25/i1/21569.
- Çevik UA, Sağlık BN, Korkut B, Özkay Y, Ilgın S. Antiproliferative, cytotoxic, and apoptotic effects of new benzimidazole derivatives bearing hydrazone moiety. J Heterocyclic Chemistry. 2017; 55:138. https://doi:10.1002/jhet.3016.
- Singh H, Lonare MK, Sharma M, Udehiya R, Singla S, Saini SP, Dumka VK. Interactive effect of carbendazim and imidacloprid on buffalo bone marrow derived mesenchymal stem cells: Oxidative stress, cytotoxicity and genotoxicity. Drug Chem Toxicol. 2021; 29:1-15. https://doi.org/10.1080/01480545.2021.2007023. PMID: 34844488.
- Caron-Beaudoin E, Viau R, Hudon-Thibeault AA, Vaillancourt C, Sanderson JT. The use of a unique co-culture model of fetoplacental steroidogenesis as a screening tool for endocrine disruptors: The effects of neonicotinoids on aromatase activity and hormone production. Toxicol Appl Pharmacol. 2017; 332:15-24. https://doi.org/10.1016/j.taap.2017.07.018. PMID: 28750898.
- Lonare M, Kumar M, Raut S, Badgujar P, Doltade S, Telang A. Evaluation of imidacloprid-induced neurotoxicity in male rats: A protective effect of curcumin. Neurochem Int. 2014; 78:122-129. https://doi.org/10.1016/j.neuint.2014.09.004. PMID: 25261201.
- Chakroun, Intissar G, Lobna E, Oumaïma A, Fadoua N, Emna K, Najjar MF, Zohra H, Hassen BC. Imidacloprid enhances liver damage in Wistar rats: Biochemical, oxidative damage and histological Assessment. J Coastal Life Med. 2017; 5(12):540-546. https://doi.org/10.12980/jclm.5.2017J7-149.
- Casida JE. Pesticide interactions: Mechanisms, benefits, and risks. J Agric Food Chem. 2017; 65(23):4553-4561. https://doi:10.1021/acs.jafc.7b01813.
- Hernández AF, Gil F, Lacasaña M. Toxicological interactions of pesticide mixtures: An update. Arch Toxicol. 2017; 91(10):3211-3223. https://doi.org/10.1007/s00204-017-2043-5. PMID: 28845507.
- Lonare MK, Vemu B, Singh AK, Dumka VK, Singla S, Sharma SK. Cytotoxicity and oxidative stress alterations induced by aldrin in BALB/c 3T3 fibroblast cells. Proc Natl Acad Sci India Sect B Biol Sci. 2017; 87:1209-1216. https://doi.org/10.1007/s40011-015-0694-7.
- Gade NE, Pratheesh MD, Nath A, Dubey PK, Amarpal, Sharma B, Saikumar G, Taru Sharma G. Molecular and cellular characterization of buffalo bone marrow-derived mesenchymal stem cells. Reprod Domest Anim. 2013; 48(3):358-367. https://doi.org/10.1111/j.1439-0531.2012.02156.x.
- Devi P, Sharma M, Singh SD, Lonare MK, Udehiya R. Viability and expression pattern of cryopreserved mesenchymal stem cells derived from buffalo bone marrow. Ruminant Sci. 2017; 6(1):7-12.
- Aranda A, Sequedo L, Tolosa L, Quintas G, Burello E, Castell JV, Gombau L. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol In Vitro. 2013; 27(2):954-963. https://doi.org/10.1016/j.tiv.2013.01.016. PMID: 23357416.
- Salmon ED, Shaw SL, Waters JC, Waterman-Storer CM, Maddox PS, Yeh E, Bloom K. A high-resolution multimode digital microscope system. Methods Cell Biol. 2007; 81:187-218. https://doi.org/10.1016/S0091-679X(06)81011-3. PMID: 17519169.
- Doan CC, Truong NH, Vu NB, Nguyen TT, Nguyen HM, Nguyen KG, Do S, Phan NK, Pham PV. Isolation, culture and cryopreservation of human bone marrow derived mesenchymal stem cells. Int J Plant Animal Env Sci. 2012; 2(2):358-367.
- Yu Y, Yao AH, Chen N, Pu LY, Fan Y, Lv L, Sun BC, Li GQ, Wang XH. Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration. Mol Ther. 2007; 15(7):1382-1389. https://doi.org/10.1038/sj.mt.6300202. PMID: 17519892.
- de Macedo Braga LM, Lacchini S, Schaan BD, Rodrigues B, Rosa K, De Angelis K, Borges LF, Irigoyen MC, Nardi NB. In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction. J Biomed Sci. 2008; 15(3):365-374. https://doi.org/10.1007/s11373-008-9237-z. PMID: 18256904.
- Peterbauer-Scherb A, van Griensven M, Meinl A, Gabriel C, Redl H, Wolbank S. Isolation of pig bone marrow mesenchymal stem cells suitable for one-step procedures in chondrogenic regeneration. J Tissue Eng Regen Med. 2010; 4(6):485-490. https://doi.org/10.1002/term.262. PMID: 20112279.
- McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol. 2009; 219(2):324-333. https://doi.org/10.1002/jcp.21670. PMID: 19115243.
- Rentsch C, Hess R, Rentsch B, Hofmann A, Manthey S, Scharnweber D, Biewener A, Zwipp H. Ovine bone marrow mesenchymal stem cells: isolation and characterization of the cells and their osteogenic differentiation potential on embroidered and surface-modified polycaprolactone-co-lactide scaffolds. In Vitro Cell Dev Biol Anim. 2010; 46(7):624-634. https://doi.org/10.1007/s11626-010-9316-0. PMID: 20490706.
- Honda H, Tomizawa M, Casida JE. Neo-nicotinoid metabolic activation and inactivation established with coupled nicotinic receptor-CYP3A4 and -aldehyde oxidase systems. Toxicol Lett. 2006; 161(2):108-114. https://doi.org/10.1016/j.toxlet.2005.08.004. PMID: 16153789.
- Tomizawa M, Lee DL, Casida JE. Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors. J Agric Food Chem. 2000; 48(12):6016-6024. https://doi.org/10.1021/jf000873c. PMID: 11312774.
- Abolaji AO, Awogbindin IO, Adedara IA, Farombi EO. Insecticide chlorpyrifos and fungicide carbendazim, common food contaminants mixture, induce hepatic, renal, and splenic oxidative damage in female rats. Hum Exp Toxicol. 2017; 36(5):483-493. https://doi.org/10.1177/0960327116652459. PMID: 27268782.
- Chauhan LK, Varshney M, Pandey V, Sharma P, Verma VK, Kumar P, Goel SK. ROS-dependent genotoxicity, cell cycle perturbations and apoptosis in mouse bone marrow cells exposed to formulated mixture of cypermethrin and chlorpyrifos. Mutagenesis. 2016; 31(6):635-642. https://doi.org/10.1093/mutage/gew031. PMID: 27470700.
- Abhishek A, Ansari NG, Shankhwar SN, Jain A, Singh V. In vitro toxicity evaluation of low doses of pesticides in individual and mixed condition on human keratinocyte cell line. Bioinformation. 2014; 31;10(12):716-720. https://doi.org/10.6026/97320630010716. PMID: 25670872.
- Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev Infect Dis. 1985; 7(5):625-634. https://doi.org/10.1093/clinids/ 7.5.625. PMID: 3903942.
- Vercesi AE, Docampo R. Ca2+ transport by digitonin-permeabilized Leishmania donovani. Effects of Ca2+, pentamidine and WR-6026 on mitochondrial membrane potential in situ. Biochem J. 1992; 284 (Pt 2)(Pt 2):463-467. https://doi.org/10.1042/bj2840463. PMID: 1376113.
- Andréo R, Regasini LO, Petrônio MS, Chiari-Andréo BG, Tansini A, Silva DH, Cicarelli RM. Toxicity and Loss of Mitochondrial Membrane Potential Induced by Alkyl Gallates in Trypanosoma cruzi. Int Sch Res Notices. 2015; 2015:924670. https://doi:10.1155/2015/924670. PMID: 27347554.
- Sakamuru S, Attene-Ramos MS, Xia M. Mitochondrial Membrane Potential Assay. Methods Mol Biol. 2016; 1473:17-22. https://doi.org/10.1007/978-1-4939-6346-1_2. PMID: 27518619.
- Area-Gomez E, Del Carmen Lara Castillo M, Tambini MD, Guardia-Laguarta C, de Groof AJ, Madra M, Ikenouchi J, Umeda M, Bird TD, Sturley SL, Schon EA. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 2012; 5; 31(21):4106-4123. https://doi.org/10.1038/emboj.2012.202. PMID: 22892566.
- Adachi M, Ishii H. Role of mitochondria in alcoholic liver injury. Free Radic Biol Med. 2002; 32(6):487-491. https://doi.org/10.1016/s0891-5849(02)00740-2. PMID: 11958949.
- Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013; 75:685-705. https://doi.org/10.1146/annurev-physiol-030212-183653. PMID: 23140366.
- Shahini A, Choudhury D, Asmani M, Zhao R, Lei P, Andreadis ST. NANOG restores the impaired myogenic differentiation potential of skeletal myoblasts after multiple population doublings. Stem Cell Res. 2018; 26:55-66. https://doi.org/10.1016/j.scr.2017.11.018. PMID: 29245050.
- Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, Verzosa GC, Pezeshki A, Khazaie K, Miller JD, van Deursen JM. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature. 2016; 530(7589):184-189. https://doi.org/10.1038/nature16932. PMID: 26840489.
- Bernstein H, Payne CM, Bernstein C, Garewal H, Dvorak K. Cancer and Aging as Consequences of Un-Repaired DNA Damage. New Research on DNA Damages. New York, USA: Nova Science Publishers; 2008. p.1-47.
- Pan MR, Li K, Lin SY, Hung WC. Connecting the dots: From DNA damage and repair to Aging. Int J Mol Sci. 2016; 17(5):685. https://doi.org/10.3390/ijms17050685. PMID: 27164092.
- Menon R, Boldogh I, Urrabaz-Garza R, Polettini J, Syed TA, Saade GR, Papaconstantinou J, Taylor RN. Senescence of primary amniotic cells via oxidative DNA damage. PLoS One. 2013; 8(12):e83416. https://doi.org/10.1371/journal.pone.0083416. PMID: 24386195.